Apremilast Is Efficacious in Refractory Alopecia Areata

The study concluded that Apremilast, an oral phosphodiesterase 4 inhibitor, was effective in treating refractory alopecia areata (AA). The research involved a small cohort of patients who had not responded to conventional therapies. The results showed significant hair regrowth in these patients, suggesting that Apremilast could be a promising treatment option for those with difficult-to-treat AA. The findings provided hope for improved management of this challenging autoimmune condition.